Loading...
Recent advances of bispecific antibodies in solid tumors
Cancer immunotherapy is the most exciting advancement in cancer therapy. Similar to immune checkpoint blockade and chimeric antigen receptor T cell (CAR-T), bispecific antibody (BsAb) is attracting more and more attention as a novel strategy of antitumor immunotherapy. BsAb not only offers an effect...
Na minha lista:
| Udgivet i: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5607507/ https://ncbi.nlm.nih.gov/pubmed/28931402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0522-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|